会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • ISOINDOLINE DERIVATIVES COMPRISING AN ADDITIONAL HETEROCYCLIC GROUP AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS
    • 包含附加杂环组的ISOINDOLINE衍生物及其在治疗疼痛症状中的应用
    • WO2009145718A1
    • 2009-12-03
    • PCT/SE2009/050615
    • 2009-05-29
    • ASTRAZENECA ABARVIDSSON, PerBESIDSKI, YevgeniCSJERNYIK, GaborLANGE, TimMACSÁRI, IstvánNILSSON, Linda
    • ARVIDSSON, PerBESIDSKI, YevgeniCSJERNYIK, GaborLANGE, TimMACSÁRI, IstvánNILSSON, Linda
    • C07D401/06A61K31/4035A61K31/4155A61K31/4192A61K31/422A61K31/444A61K31/497C07D403/06C07D413/06A61P25/04
    • C07D401/06C07D209/46C07D403/06C07D413/06
    • Compounds of formula I are claimed, wherein R 1 is hydrogen, C 1 _ 3 alkyl, C 1 _ 3 alkoxy, cyano, hydroxy or halo; wherein C 1-3 alkyl may optionally be substituted by one or more substituents independently selected from hydroxy, C 1-3 alkoxy orfluoro; and wherein Ci^alkoxy may optionally be substituted by one or more fluoro; m is 1 or 2; R 2 and R 3 is each and independently selected from hydrogen, Ci_4haloalkyl, C 1 _ 4 haloalkoxy, halo, C 1 _ 4 alkoxy, C 1 _ 4 alkyl and C 3 _ 7 cycloalkyloxy; and wherein said C 3 _ 7 cycloalkyloxy may optionally be substituted by one or more fluoro; and whereas both R 2 and R 3 can not be hydrogen; Het is selected from any one of pyridinyl, pyrazinyl, isoxazolyl, pyrazolyl, indolyl, triazolyl and pyrimidinyl, wherein each such heteroaryl may optionally be substituted by one or more X 4 ; X 4 is halo, C 1-3 alkyl, C 1-3 alkyl0C 1-3 alkyl, -CH(CH 3 )-O-C(CH 3 ) 3 ,C 1 _ 4 alkoxy, cyano, or hydroxyl, or Ci_2hydroxyalkyl;; and wherein said C 1-3 alkyl, C 1-3 alkylOC 1-3 alkyl, -CH(CH 3 )-O-C(CH 3 ) 3 , or C 1 _ 4 alkoxy may each optionally be substituted by one or more fluoro; L 1 is C 1 _ 4 alkylene, which may optionally be fluorinated or hydroxylated; and L 2 is C 1-3 alkylene; with the exception of the compounds: 2-[1-(1,5-dimethyl-lH-pyrazol-4-yl)ethyl]-5,7-dimethoxy-3-oxo-N-[2-(trifluoromethyl)benzyl]isoindoline-1-carboxamide; N-(4-fluorobenzyl)-3-oxo-2-(-pyridin-4-yletyl)isoindoline-1-carboxamide and N-(2-chlorobenzyl)-2[2-(1H-indol-3-yl)-1-methyletyl]-3-oxoisoindoline-1-carboxamide; The invention further relates to pharmaceutical compositions containing said compounds and to the use of said compounds in therapy.
    • 要求保护的式I化合物,其中R 1为氢,C 1-3烷基,C 1-3烷氧基,氰基,羟基或卤素; 其中C 1-3烷基可以任选被一个或多个独立地选自羟基,C 1-3烷氧基或氟的取代基取代; 并且其中C 1-6烷氧基可任选被一个或多个氟取代; m为1或2; R 2和R 3各自独立地选自氢,C 1-4卤代烷基,C 1-4卤代烷氧基,卤素,C 1-4烷氧基,C 1-4烷基和C 3-7环烷氧基; 并且其中所述C 3-7环烷氧基可任选被一个或多个氟取代; 而R2和R3不能是氢; Het选自吡啶基,吡嗪基,异恶唑基,吡唑基,吲哚基,三唑基和嘧啶基中的任一个,其中每个这样的杂芳基可以任选被一个或多个X 4取代; X 4是卤素,C 1-3烷基,C 1-3烷基C 1-3烷基,-CH(CH 3)-O-C(CH 3)3,C 1-4烷氧基,氰基或羟基或C 1-2羟烷基。 并且其中所述C 1-3烷基,C 1-3烷基OC 1-3烷基,-CH(CH 3)-O-C(CH 3)3或C 1-4烷氧基各自任选被一个或多个氟取代; L 1是C 1-4亚烷基,其可以任选被氟化或羟基化; 和L2是C1-3亚烷基; 除了化合物之外:2- [1-(1,5-二甲基-1H-吡唑-4-基)乙基] -5,7-二甲氧基-3-氧代-N- [2-(三氟甲基)苄基] 异吲哚啉-1-甲酰胺; N-(4-氟苄基)-3-氧代-2 - ( - 吡啶-4-基)异吲哚啉-1-甲酰胺和N-(2-氯苄基)-2 [2-(1H-吲哚-3-基) 1-methyletyl] -3- oxoisoindoline -1-甲酰胺; 本发明还涉及含有所述化合物的药物组合物和所述化合物在治疗中的用途。